Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham
Boston Scientific Corp.'s $615 million acquisition of Apollo Endosurgery Inc. announced earlier is complementary to the former's endoscopy franchise, as it leverages its gastroenterologist call point while offering the potential for it to expand into surgical endoscopy and bariatric surgery, Needham analysts aid Tuesday. The deal is expected to have no material impact on Boston Scientific's 2023 per-share earnings but to boost it after that. Needham analysts led by Mike Matson said they would wa